The Journal of Organic Chemistry
ARTICLE
zwitterionic intermediate. The final retro-Mannich27 fragmenta-
tion is also fully concerted.
(Z)-3-((2-Aminoethyl)amino)-3-(4-fluorophenyl)-1-phe-
nylprop-2-en-1-one (18a1). 1H NMR (400 MHz, CDCl3) δ 11.45
(s, 1H), 7.89 (d, J = 7.1 Hz, 2H), 7.47ꢀ7.36 (m, 5H), 7.14 (t, J = 8.1 Hz,
2H), 5.76 (s, 1H), 3.27 (dt, J = 5.8, 5.8 Hz, 2H), 2.86 (bs, 2H), 1.41 (bs,
2H); 13C NMR (100 MHz, CDCl3) δ 188.6, 165.9, 163.4 (d, J = 255.7
Hz), 140.1, 130.8, 129.9, 129.8, 128.2, 127.1, 115.6 (d, J = 22.0 Hz), 93.9,
47.8, 42.5; HRMS (CI) calcd for C17H18FN2O [M + H]+ 285.1403,
found 285.1402.
’ EXPERIMENTAL SECTION
General Information. All NMR spectra were collected at 400, 500,
and 600 MHz for 1H NMR and 100, 125, and 150 MHz for 13C NMR
using CDCl3 as solvent.
(2Z,20Z)-3,30-(Ethane-1,2-diylbis(azanediyl))bis(3-(4-fluoro-
phenyl)-1-phenylprop-2-en-1-one) (18a2). 1H NMR (600 MHz,
CDCl3) δ 11.2 (s, 1H), 7.86 (d, J = 7.3 Hz, 2H), 7.48ꢀ7.37 (m, 3H),
7.31ꢀ7.24 (m, 2H), 7.1 (t, J = 7.3 Hz, 2H), 5.73 (s, 1H), 3.33 (d, J = 3.2
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 188.9, 165.6, 163.3 (J = 250
Hz), 139.8, 131.1, 129.8, 129.7, 128.3, 127.1, 115.8, 94.6, 45.1; HRMS
(CI) calcd for C32H27F2N2O2 [M + H]+ 509.2041, found 509.2035.
1-(p-Tolyl)ethanone (19b)28. 1H NMR (400 MHz, CDCl3)
δ 7.85 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 2.58 (s, 3H), 2.41
(s, 3H).
General Procedure for the Synthesis of Ketoalkyne Com-
pounds. A stirred mixture of Pd(PPh3)2Cl2 (19 mg, 0.028 mmol) and
(11 mg, 0.056 mmol) of CuI in THF (5 mL) was purged with nitrogen
for 30 min. Then 0.2 mL (1.42 mmol) of triethylamine, 1.42 mmol of
acid chloride, and acetylene (1.7 mmol) were added successively. The
reaction mixture was then stirred for 3 h at room temperature. Solvents
were evaporated, and the residue was chromatographed on silica gel
(ethyl acetate/hexane) to give the pure product.
General Procedure for the Alkyne Fragmentation. To a
solution of ketoalkyne compound (0.25 mmol) in 2.5 mL of THF in a sealed
tube was added neat ethylenediamine (0.25 mmol) via a syringe. Depending
on the condition the temperature was raised to 110 or 125 °C and stirred for
around 12ꢀ20 h. Solvent was carefully removed under reduced pressure,
and the yield of the product was determined from crude reaction mixture by
using 1H NMR experiment with benzyl phenyl ether as internal standard.
Acetophenone (16b)28. 1H NMR(400 MHz, CDCl3) δ7.98ꢀ7.95
(m, 2H), 7.58ꢀ7.55 (m, 1H), 7.48ꢀ7.44 (m, 2H), 2.61 (s, 3H).
(Z)-3-((2-Aminoethyl)amino)-3-phenyl-1-(p-tolyl)prop-2-
en-1-one (19a1). 1H NMR (400 MHz, CDCl3) δ 11.45 (s, 1H), 7.80
(d, J = 7.9 Hz, 2H), 7.48ꢀ7.38 (m, 5H), 7.19 (d, J = 7.9 Hz, 2H), 5.78 (s,
1H), 3.27 (dt, J = 6.2, 6.0 Hz, 2H), 2.84 (t, J = 6.0 Hz, 2H), 2.37 (s, 3H),
1.45 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 188.5, 166.7, 141.1,
137.6, 135.8, 129.4, 128.9, 128.6, 127.1, 93.6, 47.8, 42.6, 21.4; HRMS
(CI) calcd for C18H21N2O [M + H]+ 281.1654, found 281.1665.
(2Z,20Z)-3,30-(Ethane-1,2-diylbis(azanediyl))bis(3-phenyl-
1-(p-tolyl)prop-2-en-1-one) (19a2). 1H NMR (400 MHz, CDCl3)
δ 11.2 (s, 1H), 7.77 (d, J = 8.2 Hz, 2H), 7.49ꢀ7.36 (m, 3H), 7.31ꢀ7.24
(m, 2H), 7.19 (d, J = 7.8 Hz, 2H), 5.73 (s, 1H), 3.34 (t, J = 3.2 Hz, 2H),
2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 188.7, 166.7, 141.3, 137.3,
135.5, 129.5, 128.9, 127.8, 127.7, 127.2, 94.2, 45.1, 21.5; HRMS (CI)
calcd for C34H33N2O2 [M + H]+ 501.2542, found 501.2536.
29
1
2-Phenyl-4,5-dihydro-1H-imidazole (16c) . H NMR (400
MHz, CDCl3) δ 7.82 (d, J = 7.8 Hz, 2H), 7.40ꢀ7.47 (m, 3H), 6.92 (bs,
1H), 3.60 (s, 4H).
(Z)-3-((2-Aminoethyl)amino)-1,3-diphenylprop-2-en-1-one
(16a1). 1H NMR (400 MHz, CDCl3) δ 11.49 (bs, 1H), 7.89 (d, J = 6.6
Hz, 2H), 7.48ꢀ7.36 (m, 8H), 5.79 (s, 1H), 3.28 (dt, J = 6.1, 5.7 Hz, 2H),
2.86 (bs, 2H), 1.48 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 188.1,
166.7, 139.9, 135.3, 130.4, 129.2, 128.3, 127.9, 127.4, 126.7, 93.4, 47.4,
42.2; HRMS (CI) calcd for C17H19N2O [M + H]+ 267.1497, found
267.1493.
3,30-(Ethane-1,2-diylbis(azanediyl))bis(1,3-diphenylprop-
2-en-1-one) (16a2). 1H NMR (600 MHz, CDCl3) δ 11.26 (bs, 1H),
7.87 (d, J = 6.7 Hz, 2H), 7.48ꢀ7.36 (m, 6H), 7.30 (d, J = 6.7 Hz, 2H),
5.75 (s, 1H), 3.35 (t, J = 3.2 Hz, 2H); 13C NMR (150 MHz, CDCl3) δ
188.7, 166.6, 140.0, 135.1, 130.8, 129.5, 128.7, 128.2, 127.6, 127.1, 94.5,
45.1; HRMS (CI) calcd for C32H29N2O2 [M + H]+ 473.2229, found
473.2231.
18
1
1-(4-Fluorophenyl)ethanone (20b) . H NMR (400 MHz,
CDCl3) δ 8.01ꢀ7.97 (m, 2H), 7.16ꢀ7.11 (m, 2H), 2.60 (s, 3H).
(Z)-3-((2-Aminoethyl)amino)-1-(4-fluorophenyl)-3-phenyl-
prop-2-en-1-one (20a1). 1H NMR (600 MHz, CDCl3) δ 11.46
(s, 1H), 7.90 (dd, J = 8.7, 5.6 Hz, 2H), 7.48ꢀ7.39 (m, 5H), 7.06 (dd,
J = 8.6, 8.6 Hz, 2H), 5.73 (s, 1H), 3.28 (dt, J = 6.2, 6.1 Hz, 2H), 2.85 (t, J =
6.2 Hz, 2H), 1.41 (bs, 2H); 13C NMR (150 MHz, CDCl3) δ 187.1, 167.1,
164.5 (d, J = 250.3 Hz), 136.0 (d, J = 124.1Hz), 129.6, 129.3, 128.6, 127.7,
115.0, 115.1, 93.3, 47.8, 42.5; HRMS (CI) calcd for C17H18FN2O
[M + H]+ 285.1403, found 285.1404.
(2Z,20Z)-3,30-(Ethane-1,2-diylbis(azanediyl))bis(1-(4-fluoro-
phenyl)-3-phenylprop-2-en-1-one) (20a2). 1H NMR (400 MHz,
CDCl3) δ 11.21 (s, 1H), 7.87 (dd, J = 8.6, 5.2 Hz, 2H), 7.47ꢀ7.37
(m, 3H), 7.29ꢀ7.23 (m, 2H), 7.06 (t, J = 8.6 Hz, 2H), 5.69 (s, 1H), 3.34
(t, J = 3.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 187.5, 166.7, 164.6
(d, J = 250.2 Hz), 135.6 (d, J = 124.0 Hz), 129.6, 129.4, 129.3, 128.7, 127.6,
115.2, 94.3, 44.9; HRMS (CI) calcd for C32H27F2N2O2 [M + H]+
509.2041, found 509.2028.
2-(p-Tolyl)-4,5-dihydro-1H-imidazole (17c)28. 1H NMR (400
MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 2H), 7.21 (d, J = 8.1 Hz, 2H), 5.03
(bs, 1H), 3.78 (s, 4H), 2.39 (s, 3H).
(Z)-3-((2-Aminoethyl)amino)-1-phenyl-3-(p-tolyl)prop-2-
en-1-one (17a1). 1H NMR (400 MHz, CDCl3) δ 11.49 (s, 1H), 7.89
(d, J = 7.0 Hz, 2H), 7.46ꢀ7.36 (m, 3H), 7.32 (d, J = 7.1 Hz, 2H),
7.28ꢀ7.21 (m, 2H), 5.78 (s, 1H), 3.29 (dt, J = 5.1, 5.0 Hz, 2H), 2.85 (bs,
2H), 2.41 (s, 3H), 1.45 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 188.4,
167.3, 140.4, 139.7, 132.8, 130.7, 129.3, 128.2, 127.8, 127.1, 93.7, 47.8,
42.6, 21.4; HRMS (CI) calcd for C18H21N2O [M + H]+ 281.1659, found
281.1654.
30
1
1-(4-Chlorophenyl)ethanone (21b) . H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 8.8 Hz, 2H), 7.42 (d, J = 8.8 Hz, 2H), 2.58 (s, 3H).
(Z)-3-((2-Aminoethyl)amino)-1-(4-chlorophenyl)-3-phenyl-
1
prop-2-en-1-one (21a1). H NMR (600 MHz, CDCl3) δ 11.5 (bs,
(2Z,20Z)-3,30-(Ethane-1,2-diylbis(azanediyl))bis(1-phenyl-
3-(p-tolyl)prop-2-en-1-one) (17a2). 1H NMR (400 MHz, CDCl3)
δ 11.24 (s, 1H), 7.85 (d, J = 7.4 Hz, 2H), 7.46ꢀ7.34 (m, 5H), 7.19 (d, J =
9.0 Hz, 2H), 5.74 (s, 1H), 3.36 (d, J = 3.4 Hz, 2H), 2.41 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 188.6, 166.9, 140.2, 135.1, 139.7, 132.3,
130.8, 129.4, 128.2, 127.6, 127.1, 94.3, 45.1, 21.4; HRMS (CI) calcd for
C34H33N2O2 [M + H]+ 501.2542, found 501.2548.
1H), 7.83 (d, J = 8.4 Hz, 2H), 7.47ꢀ7.44 (m, 3H), 7.43ꢀ7.39 (m, 2H),
7.36 (d, J = 8.4 Hz, 2H), 5.73 (s, 1H), 3.28 (dt, J = 6.1, 6.1 Hz, 2H), 2.86
(t, J = 6.1 Hz, 2H), 1.41 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 186.9,
167.3, 138.6, 136.8, 135.5, 129.6, 128.6, 128.5, 128.4, 127.7, 93.3, 47.8, 42.4;
HRMS(CI) calcdfor C17H18N2OCl [M + H]+ 301.1108, found 301.1114.
(2Z,20Z)-3,30-(Ethane-1,2-diylbis(azanediyl))bis(1-(4-chloro-
phenyl)-3-phenylprop-2-en-1-one) (21a2). 1H NMR (600
MHz, CDCl3) δ 11.30 (s, 1H), 7.80 (d, J = 8.5 Hz, 2H), 7.45 (d, J =
7.4 Hz, 1H), 7.39 (t, J = 7.4 Hz, 2H), 7.36 (d, J = 8.3 Hz, 2H), 7.25 (d, J =
8.3 Hz, 2H), 5.69 (s, 1H), 3.34 (t, J = 3.0 Hz, 2H); 13C NMR (100 MHz,
2-(4-Fluorophenyl)-4,5-dihydro-1H-imidazole (18c)18. 1H
NMR (400 MHz, CDCl3) δ 7.78ꢀ7.83 (m, 2H), 7.06 (t, J = 8.6 Hz,
2H), 5.59 (bs, 1H), 3.78 (s, 4H).
7487
dx.doi.org/10.1021/jo201259j |J. Org. Chem. 2011, 76, 7482–7490